Good you joined!

Good you joined!

Have a question for Dr. Afolabi or any of our presenters? We’d love to hear from you. Share in the Q&A window (click “Q&A”) at the bottom of your Zoom screen.

Hi Raffaela. Good to "see" you after a long time. I hope you are well.

Hi Anna, I see you've raised your hand. Can I assist?

@Dr Afolabi - I plan to pose the first question to you. Adapted from Mark Hathway, I will ask you: "What are options to expand access to LARCs including the hormonal IUS to rural and disadvantaged populations?

Dr. Afolabi - does that sound okay as a question for you to address?

@Loyce - I will as you the same question if that works

Dr. Afolabi, what is the duration of training for TOTs and providers in Nigeria?

Please keep the great questions coming — Just click “Q&A” at the bottom of your Zoom screen to ask a question.

Great presentation Loyce

Great presentation Prof Luis!

And Loyce and Dr. Afolabi

Great job, panelists. Note: if you’re done presenting, feel free to look at the Q&A window and respond (click “Type Answer”) to any questions relevant to your presentation.

Excellent country learnings! thank you Dr. Afolabi, Dr.Loyce and Dr. Luis.

@Luis - I will ask the same question to you next. hope that works!

Have a question or comment for Dr. Todd? Please click “Q&A” at the bottom of your Zoom screen to submit.

Have a question or comment about postpartum women and hormonal IUS? Please click “Q&A” at the bottom of your Zoom screen to submit.

Under A1. Would this include what method, if any, the client was on previously?

Check out the Hormonal IUS Access Portal—a new online clearinghouse for global information about the hormonal IUS: www.iusportal.org

Good to hear about how provider onfidence stemming from the inserter design. Clearly innovation and product improvements relate to not only the contraceptive but also to the inserter.

Thank you Mark for your question. As one of the slide suggested, some of the Hormonal IUS sites in Kenya were also part of a new program on group antenatal care, similar to the centering childbirth model in the US, where groups of women at similar gestational stage come together for both the ANC physical check up and a group discussion. This allows for rich discussion of contraception options and timing of starting a method. Also a study we conducted in Ethiopia with Health Extension workers and health centers which emphasize repeated PPFP counseling in ANC until a woman has decided on a voluntary plan for her post-partum contraceptive use including LAM or no method, and whether she will use a facility birth or PNC or immunization visit to access the method of her choice. This was supported by modifications to the IMCH cards that HEWs use to support their care to women along the continuum of care.

The qualitative portion of that study in Ethiopia is published by Yigzaw et al on Gates Open Research

I answered it in the chat! thanks for the softball!

Thanks Ashley and others for creating the portal and making a convenient place to have all the resources and evidence around Hormonal IUS!

Share your question or comment on the provision of LARCs in the era of COVID-19 in the Q&A tool at the bottom of your Zoom screen.

Thank you @Sadiah Pal - we will circle back to this question at the end

Dr. Bahamondes presentation from the case study in Brazil indicated that about a quarter of LNG IUS insertions were for managing heavy menstrual bleeding.

Check out the Hormonal IUS Access Portal—a new online clearinghouse for global information about the hormonal IUS: www.iusportal.org

Thanks Drs. Saad and Gathari. Refreshing to have these guidance/practices for continuity summarized and demonstrated in practice.

Congratulation to Tabitha and team for a productive 2 day webinar.

Congratulations to organizers and all presenters for a fruitful meeting

Thank you!